Cargando…
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
BACKGROUND: Agreement on the utility of imaging follow-up in patients with high-risk melanoma is lacking. A UK consensus statement recommends a surveillance schedule of CT or positron-emission tomography-CT and MRI brain (every 6 months for 3 years, then annually in years 4 and 5) as well as clinica...
Autores principales: | Lim, Kok Haw Jonathan, Spain, Lavinia, Barker, Claire, Georgiou, Alexandros, Walls, Gerard, Gore, Martin, Turajlic, Samra, Board, Ruth, Larkin, James M, Lorigan, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844377/ https://www.ncbi.nlm.nih.gov/pubmed/29531842 http://dx.doi.org/10.1136/esmoopen-2017-000317 |
Ejemplares similares
-
New survival standards for advanced melanoma
por: Spain, Lavinia, et al.
Publicado: (2020) -
How we treat neurological toxicity from immune checkpoint inhibitors
por: Spain, Lavinia, et al.
Publicado: (2019) -
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
por: Switzer, Benjamin, et al.
Publicado: (2021) -
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma
por: Favara, David M, et al.
Publicado: (2020) -
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
por: Flynn, Michael, et al.
Publicado: (2018)